Swallowable and self-absorbing novel intragastric balloon for mild obesity: a case report

doi:10.3877/cma.j.issn.2095-9605.2023.03.012

Abstract

Abstract:

The new type of swallowable and self absorbing intragastric balloon (Allurion Balloon) does not require endoscopic assistance and can be swallowed through the oral cavity. After being placed for 4-6 months, the liquid inside the balloon will be discharged, making it a simpler, safer, and more effective weight loss device. This article reports a case of successful insertion of a swallowable and self-absorbing novel intragastric balloon for the treatment of mild obesity.

Key words: Obesity, Swallowing, Self-absorption, Intragastric balloon

Xiaomei Chen, Wenhui Chen, Wan'e Zhao, Jie Guo, Chao Su, Zhiju Fu, Wah Yang, Zhiyong Dong, Cunchuan Wang. Swallowable and self-absorbing novel intragastric balloon for mild obesity: a case report[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09(03): 215-217.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfpydxbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9605.2023.03.012

https://zhfpydxbdzzz.cma-cmc.com.cn/EN/Y2023/V09/I03/215

Figures/Tables 2

References 17

[1]	Kasama K, Mui W, Lee WJ, et al. IFSO-APC consensus statements 2011 [J]. Obes Surg, 2012, 22(5): 677-684.
[2]	Benaiges D, Goday A, Pedro-Botet J, et al. Bariatric surgery: to whom and when? [J]. Minerva Endocrinol, 2015, 40(2): 119-28.
[3]	English WJ, DeMaria EJ, Brethauer SA, et al. American Society for Metabolic and Bariatric Surgery estimation of metabolic and bariatric procedures performed in the United States in 2016 [J]. Surg Obes Relat Dis, 2018, 14(3): 259-63.
[4]	Kassir R, Debs T, Blanc P, et al. Complications of bariatric surgery: Presentation and emergency management [J]. Int J Surg, 2016, 2777-2781.
[5]	Machytka E, Gaur S, Chuttani R, et al. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study [J]. Endoscopy, 2017, 49(2): 154-160.
[6]	Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon [J]. Obes Surg, 2004, 14(7): 991-998.
[7]	Ribeiro IB, Kotinda A, Sánchez-Luna SA, et al. Adverse Events and Complications with Intragastric Balloons: a Narrative Review (with Video) [J]. Obes Surg, 2021, 31(6): 2743-2752.
[8]	Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: The Italian Experience with 2, 515 Patients [J]. Obes Surg, 2005, 15(8): 1161-1164.
[9]	Taha O, Abdelaal M, Asklany A, et al. Outcomes of a Swallowable Intragastric Balloon (Elipse™) on 96 Overweight and Obese Patients [J]. Obes Surg, 2021, 31(3): 965-969.
[10]	Espinet Coll E, Carrasco Clavijos S, Díaz Galán P, et al. Feasibility, results and endoscopic requirements of the Elipse® swallowable intragastric balloon: initial experience [J]. Rev Esp Enferm Dig, 2019, 111(12): 921-926.
[11]	Jense MTF, Palm-Meinders IH, Sanders B, et al. The Swallowable Intragastric Balloon Combined with Lifestyle Coaching: Short-Term Results of a Safe and Effective Weight Loss Treatment for People Living with Overweight and Obesity [J]. Obes Surg, 2023, 33(6): 1668-1675.
[12]	Ienca R, Giardiello C, Scozzarro A, et al. Improving Nausea and Vomiting Post-Elipse Balloon: a Novel Single-Dose Regimen of 300 mg Netupitant/0.5 mg Palonosetron Hydrochloride [J]. Obes Surg, 2019, 29(9): 2952-2956.
[13]	Sullivan S, Swain J, Woodman G, et al. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss [J]. Surg Obes Relat Dis, 2018, 14(12): 1876-1889.
[14]	Moore RL, Seger MV, Garber SM, et al. Clinical safety and effectiveness of a swallowable gas-filled intragastric balloon system for weight loss: consecutively treated patients in the initial year of U.S. commercialization [J]. Surg Obes Relat Dis, 2019, 15(3): 417-423.
[15]	Vantanasiri K, Matar R, Beran A, et al. The Efficacy and Safety of a Procedureless Gastric Balloon for Weight Loss: a Systematic Review and Meta-Analysis [J]. Obes Surg, 2020, 30(9): 3341-3346.
[16]	Abu Dayyeh BK, Maselli DB, Rapaka B, et al. Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial [J]. Lancet, 2021, 398(10315): 1965-1973.
[17]	Ienca R, Al Jarallah M, Caballero A, et al. The Procedureless Elipse Gastric Balloon Program: Multicenter Experience in 1770 Consecutive Patients [J]. Obes Surg, 2020, 30(9): 3354-3362.

Please choose a citation manager

Content to export